Your browser doesn't support javascript.
loading
The anti-tumor and renoprotection study of E-[c(RGDfK)2]/folic acid co-modified nanostructured lipid carrier loaded with doxorubicin hydrochloride/salvianolic acid A.
Zhang, Bing; Zhang, Ying; Dang, Wenli; Xing, Bin; Yu, Changxiang; Guo, Pan; Pi, Jiaxin; Deng, Xiuping; Qi, Dongli; Liu, Zhidong.
Afiliação
  • Zhang B; State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
  • Zhang Y; Haihe Laboratory of Modern Chinese Medicine, Tianjin, 301617, China.
  • Dang W; Engineering Research Center of Modern Chinese Medicine Discovery and Preparation Technique, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
  • Xing B; College of Food and Biological Engineering, Xuzhou University of Technology, Xuzhou, 221008, China.
  • Yu C; State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
  • Guo P; Haihe Laboratory of Modern Chinese Medicine, Tianjin, 301617, China.
  • Pi J; Engineering Research Center of Modern Chinese Medicine Discovery and Preparation Technique, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
  • Deng X; State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
  • Qi D; Haihe Laboratory of Modern Chinese Medicine, Tianjin, 301617, China.
  • Liu Z; Engineering Research Center of Modern Chinese Medicine Discovery and Preparation Technique, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
J Nanobiotechnology ; 20(1): 425, 2022 Sep 24.
Article em En | MEDLINE | ID: mdl-36153589

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Doxorrubicina / Antibióticos Antineoplásicos Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Doxorrubicina / Antibióticos Antineoplásicos Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article